PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10927967

Managing one's body using self-management techniques: practicing autonomy.

D Willems
View original source ↗Export metadata ↓

Abstract

This paper discusses some of the anthropological and philosophical features of the use of self-management plans by patients with a chronic disease, focusing on patients with asthma. Characteristics of this technologically mediated form of self-care are contrasted with the work of Mauss and Foucault on body techniques and techniques of self. The similarities and differences between self-management of asthma and Foucault's technologies of self highlight some of the ways in which self-management contributes to modifications in the definitions of patients and physicians. Patients, in measuring their lung function, first come to rely on measurements more than on felt disturbances, but next, felt disturbances become modified by previous measurements. Physicians, one the other hand, see their role changed from expert to being a participant in a joint treatment. It is argued that the concept of agency is more appropriate for describing the advantage of self-management for patients than autonomy.

Explore related subjects

Anti-Asthmatic AgentsAsthmaBiomedical TechnologyHumansPersonal AutonomyPhilosophy, MedicalPhysician's RoleRespiratory Function TestsSelf CarePhilosophical ApproachProfessional Patient RelationshipJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D Willems. 2000. Managing one's body using self-management techniques: practicing autonomy.. https://doi.org/10.1023/a%3A1009995018677

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Providers underestimate symptom severity among urban children with asthma.

BACKGROUND: Guidelines recommend that children with mild persistent to severe persistent asthma receive maintenance anti-inflammatory medications. However, providers may not be aware of the severity of their patients' symptoms. The underestimation of severity may contribute to poor adherence to asthma care guidelines. OBJECTIVES: To describe the use of preventive medications among a group of urban children with mild persistent to severe persistent asthma and to evaluate the degree to which their health care providers are aware of their asthma severity. DESIGN: Children (ages 4-6 years) from urban schools in Rochester, NY, were eligible if their parents reported mild persistent to severe persistent asthma symptoms. Each child's health care provider was asked to assess the child's asthma severity and use of medications based both on their knowledge of the child and review of the medical record. Parent and provider assessments were compared. Bivariate and regression analyses were used to identify factors associated with concordant classifications of asthma severity. RESULTS: Ninety children with parent-defined mild persistent to severe persistent asthma participated (64% boys, 67% black, 73% receiving Medicaid). Only 40% of the children were described accurately by their providers as having mild persistent to severe persistent asthma, and only 50% of the total had been prescribed maintenance medications. Thirty-six percent of families reported that their child used maintenance medications daily. In contrast, most of the children who were classified by their provider as having mild persistent to severe persistent asthma were prescribed a maintenance medication (83%), and 58% used them daily. Sociodemographic characteristics and asthma severity were not associated with provider accuracy. CONCLUSIONS: Most children in this study were not accurately classified by their providers as having mild persistent to severe persistent asthma and had not been prescribed maintenance medications. When providers were aware of their patient's asthma symptoms, most of the children were prescribed maintenance medications. Attempts to improve adherence to asthma guidelines should take into consideration provider underestimations of asthma severity.

Anti-Asthmatic Agents↗
PubMed2002

Antileukotrienes in clinical development for asthma.

Asthma is a serious world health problem characterised by a chronic inflammatory disorder of the airways. Asthma attacks, or exacerbations, are episodic but airway inflammation is chronically present. Thus, this disorder requires long-term management. The goals of asthma management include prevention steps for long-term control, action steps to stop attacks, recognising deteriorating asthma, how to treat deteriorating asthma, how and when to seek medical attention and education. In order to achieve the best therapeutic choice, a stepwise approach should be adopted. In recent years, much progress regarding the characterisation of leukotrienes (LTs) has been achieved. These substances are important products of action of the 5-lipoxygenase (5-LO) enzyme on arachidonic acid (AA) and it has been established that the leukotrienes are key mediators of both allergy and inflammation. Consequently, the important role of the cysteinyl-leukotrienes (Cys-LTs) in the pathophysiology of bronchial asthma has been suggested. Pharmacological support for the role of Cys-LTs in asthma has been observed using inhibitors of 5-LO and specific LT receptor antagonists. In the clinical setting, the LT receptor, which plays the most important role, is the Cys-LT1 receptor. The antagonists of this receptor have proven an effective therapy in chronic asthmatics, agonist antigens and exercise-induced bronchoconstriction and in aspirin-intolerant asthmatics. These drugs provide a new approach in asthmatic therapy and therefore may facilitate the compliance of daily therapy.

Anti-Asthmatic Agents↗